ANTITHYMOCYTE IMMUNOGLOBULIN for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where ANTITHYMOCYTE IMMUNOGLOBULIN was used for Bone marrow conditioning regimen.
Most Reported Side Effects for ANTITHYMOCYTE IMMUNOGLOBULIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute graft versus host disease | 22 | 27.2% | 9 | 0 |
| Autoimmune haemolytic anaemia | 12 | 14.8% | 1 | 0 |
| Acute lymphocytic leukaemia recurrent | 10 | 12.4% | 8 | 0 |
| Chronic graft versus host disease | 10 | 12.4% | 3 | 0 |
| Drug ineffective | 10 | 12.4% | 8 | 1 |
| Graft versus host disease | 10 | 12.4% | 7 | 1 |
| Therapeutic response decreased | 10 | 12.4% | 1 | 0 |
| Thrombocytopenia | 6 | 7.4% | 2 | 0 |
| Acute myeloid leukaemia recurrent | 5 | 6.2% | 5 | 0 |
| Epstein-barr virus infection | 5 | 6.2% | 0 | 1 |
| Post transplant lymphoproliferative disorder | 5 | 6.2% | 3 | 0 |
Other Indications for ANTITHYMOCYTE IMMUNOGLOBULIN
Prophylaxis against graft versus host disease (38)
Stem cell transplant (12)
Aplastic anaemia (5)
Immunosuppression (5)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)